| Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer M Asim, F Tarish, HI Zecchini, K Sanjiv, E Gelali, CE Massie, A Baridi, ... Nature communications 8 (1), 374, 2017 | 251 | 2017 |
| A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients P Sooriakumaran, A Srivastava, SF Shariat, PD Stricker, T Ahlering, ... European urology 66 (3), 450-456, 2014 | 182 | 2014 |
| International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta‐analysis of 1446 patients GL Shaw, P Wilson, J Cuzick, DM Prowse, SL Goldenberg, NA Spry, ... BJU international 99 (5), 1056-1065, 2007 | 135 | 2007 |
| Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing N Vasiljević, K Wu, AR Brentnall, DC Kim, MA Thorat, SC Kudahetti, ... Disease markers 30 (4), 151-161, 2011 | 105 | 2011 |
| Identification of pathologically insignificant prostate cancer is not accurate in unscreened men GL Shaw, BC Thomas, SN Dawson, G Srivastava, SL Vowler, ... British journal of cancer 110 (10), 2405-2411, 2014 | 85 | 2014 |
| HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E 2 F 1‐mediated cell cycle network A Ramos‐Montoya, AD Lamb, R Russell, T Carroll, S Jurmeister, ... EMBO molecular medicine 6 (5), 651-661, 2014 | 83 | 2014 |
| Hedgehog signalling in androgen independent prostate cancer G Shaw, AM Price, E Ktori, I Bisson, PE Purkis, S McFaul, RTD Oliver, ... European urology 54 (6), 1333-1343, 2008 | 80 | 2008 |
| Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling G Shaw, DM Prowse Cancer cell international 8, 1-11, 2008 | 73 | 2008 |
| High‐resolution genome‐wide copy‐number analysis suggests a monoclonal origin of multifocal prostate cancer LK Boyd, X Mao, L Xue, D Lin, T Chaplin, SC Kudahetti, E Stankiewicz, ... Genes, Chromosomes and Cancer 51 (6), 579-589, 2012 | 71 | 2012 |
| The early effects of rapid androgen deprivation on human prostate cancer GL Shaw, H Whitaker, M Corcoran, MJ Dunning, H Luxton, J Kay, ... European urology 70 (2), 214-218, 2016 | 69 | 2016 |
| Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study P Rouse, G Shaw, HU Ahmed, A Freeman, C Allen, M Emberton Urologia internationalis 87 (1), 49-53, 2011 | 69 | 2011 |
| Learning curves for robotic surgery: a review of the recent literature G Mazzon, A Sridhar, G Busuttil, J Thompson, S Nathan, T Briggs, J Kelly, ... Current Urology Reports 18, 1-6, 2017 | 61 | 2017 |
| Encrustation of biomaterials in the urinary tract GL Shaw, SK Choong, C Fry Urological research 33, 17-22, 2005 | 61 | 2005 |
| Surgical techniques to optimize early urinary continence recovery post robot assisted radical prostatectomy for prostate cancer AN Sridhar, M Abozaid, P Rajan, P Sooriakumaran, G Shaw, S Nathan, ... Current Urology Reports 18, 1-8, 2017 | 60 | 2017 |
| Rectal fistulae after salvage high‐intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy HU Ahmed, A Ishaq, E Zacharakis, G Shaw, R Illing, C Allen, A Kirkham, ... BJU international 103 (3), 321-323, 2009 | 58 | 2009 |
| The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis L Xu, X Mao, T Guo, PY Chan, G Shaw, J Hines, E Stankiewicz, Y Wang, ... Clinical Cancer Research 23 (17), 5112-5122, 2017 | 57 | 2017 |
| Is microscopic haematuria a urological emergency? MA Khan, G Shaw, AMI Paris BJU international 90 (4), 355-357, 2002 | 56 | 2002 |
| Mortality among men with advanced prostate cancer excluded from the ProtecT trial TJ Johnston, GL Shaw, AD Lamb, D Parashar, D Greenberg, T Xiong, ... European urology 71 (3), 381-388, 2017 | 55 | 2017 |
| Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target M Asim, CE Massie, F Orafidiya, N Pértega-Gomes, AY Warren, ... Journal of the National Cancer Institute 108 (5), djv371, 2016 | 52 | 2016 |
| Polymorphism and single nucleotide polymorphisms (SNP s) G Shaw BJU international 112 (5), 664-665, 2013 | 49 | 2013 |
